
Iantrek Hits 2,000 Procedures for New Bio-Interventional Technology - AlloFlo™ Uveo
WHITE PLAINS, N.Y., May 06, 2025 (GLOBE NEWSWIRE) -- Iantrek, Inc., a leader in bio-interventional ophthalmic surgery (BIOS), today announced it has surpassed 2,000 AlloFlo™ Uveo procedures in the U.S., a key milestone ahead of its full commercial launch …